Deep Tech Startups

Infinite Frontiers is an independent media platform launched in March 2023 that publishes content about deep technology companies and their founders. The platform operates a weekly newsletter covering deep tech funding, research, and ecosystem news, and hosts a longform interview series with deep tech founders and investors.

1 investor

Infinitesima develops atomic precision 3D metrology technology for the semiconductor industry, including the Rapid Probe Microscope (RPM) that uses thermal-optical actuation and an interferometric measurement system to achieve picometer-precision surface measurement faster than conventional atomic force microscopes. Based near Oxford, UK, it serves semiconductor manufacturers worldwide.

1 investor

Infiscale develops a compiler-based software toolchain and unified platform supporting CPUs, GPUs, and NPUs to build a domestic AI chip software ecosystem in China. It offers low-cost, cross-brand standardized AI software infrastructure and edge computing chip solutions for AI applications.

1 investor

Inflection is a venture capital firm that backs a small number of engineering-focused "moonshot" startups per year, seeking high-risk, high-upside deep tech ventures across Western tech. It optimizes for asymmetric returns and works closely with technical founders from early stages.

1 investor

InfraLytiks applies machine learning and AI to analyze and visualize multi-spectral and multi-dimensional data from multiple sources. The company provides custom data processing and analysis approaches for complex datasets.

1 investor

Infusd develops solubility technology that converts fat-soluble and insoluble nutrients into water-soluble solutions with improved stability and bioavailability. It supplies this ingredient-delivery technology to consumer brands making food, beverage, and nutritional products.

1 investor

InfuSense develops an electrochemical sensing technology platform that detects analytes at sub-therapeutic levels, delivering sample analysis results within minutes. The portable device is designed to bring laboratory-scale testing capabilities into a handheld form factor.

1 investor

iNGage develops high-performance navigation sensors based on MEMS (micro-electro-mechanical systems) technology for high-volume applications. The fabless semiconductor company serves the navigation and inertial sensor market.

1 investor

Ingrain analyzes complex rock types using high-resolution CT scanning to characterize reservoirs and identify high-potential "sweet spots" for oil and gas clients. It provides digital rock physics analysis to help operators maximize reservoir production.

1 investor

Inhance Technologies develops specialty chemicals, gases, and material technologies for customers across agriculture, healthcare, automotive, and electronics industries. The company provides customized solutions ranging from lab-scale samples to large-volume manufacturing across four continents.

1 investor

Inherent develops general-purpose AI agents designed to augment scientific research and discovery across disciplines. The company builds AI systems that operate within redesigned R&D organizations to accelerate innovation through human-machine collaboration rather than automation.

1 investor

Inheritance develops deep learning systems that convert raw video into structured behavioral data for training robots and world models. The company enables robotics to scale by making video machine-readable so that robots can learn from visual data at scale, similar to how language models learn from text.

1 investor

Inimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases. The company combines immunology and vaccine expertise to advance its clinical and pre-clinical pipeline.

1 investor

iniVation develops neuromorphic vision technology for high-performance, low-power imaging systems serving both consumer and industrial applications.

1 investor

Inklusion designs immersive experiences using extended reality, digital twins, and artificial intelligence across training, games, and manufacturing applications.

1 investor

InkVivo Technologies develops polymer-based drug delivery platforms (GARD/gastroretentive and SHEALD/injectable) for controlled, localized, and sustained release of small molecules and biologics. An ETH Zurich spin-off, it works with pharmaceutical and nutraceutical partners to improve bioavailability and patient adherence, with programs targeting iron deficiency anemia and neurodegenerative diseases.

1 investor

Inner Logic builds development infrastructure for procedural medical devices such as orthopedic implants, heart valves, and surgical robots, using cloud-based simulation to move device programs from concept to evidence-backed iteration. Its tools aim to reduce physical and cadaveric testing while keeping development cycles traceable and documented for regulatory submissions.

1 investor

Innorna develops mRNA-based therapeutics built on a proprietary platform featuring a lipid library of over 100,000 ionizable lipid structures and targeted LNP delivery systems. The company's pipeline spans vaccines, protein replacement therapies for chronic metabolic diseases, and in vivo immunotherapies for autoimmune conditions, with four candidates in clinical trials.

1 investor

Innospark is a venture capital firm that invests in AI-native companies and founders building technology-driven solutions across enterprise, healthcare, and physical-world applications. The firm focuses on companies leveraging artificial intelligence and computational technologies to solve complex problems.

1 investor

Innosphere is a technology economic development organization that operates incubators and venture capital programs focused on climate resilience, life sciences, and smart cities, serving early-stage companies and communities across the Mountain Plains region.

1 investor

Innosphere Ventures is a venture capital and economic development organization that operates incubators and venture capital funds focused on technology sectors including climate resilience, life sciences, and smart cities. The organization serves early-stage entrepreneurs and innovators across the Mountain Plains region.

1 investor

InnoSyn produces recombinant pig liver esterase enzymes and screening kits for use in organic chemistry applications, particularly for asymmetric synthesis and racemic resolution of chiral compounds. The company supplies these biotech research products to pharmaceutical and chemical synthesis professionals.

1 investor

Innoup Farma is a pharmaceutical company developing oral immunotherapies and novel drug formulations, including mRNA-based vaccines and treatments for allergies, cancer, and rare diseases. The company is based in Spain and works on translating innovative biotech solutions into clinical applications.

1 investor

Innovation Works is a Pittsburgh-based startup investor whose portfolio page presents companies across software, robotics, healthcare, and hardware in Southwestern Pennsylvania. The page profiles portfolio companies rather than a single product.

1 investor